Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancies

被引：0
|
作者：
Rejeski, K. [1 ,2 ,3 ]
Tebaldi, T. [1 ]
Joshi, P. [1 ]
Liang, Y. [1 ]
Pfeifer, D. [2 ]
Luebbert, M. [2 ]
Halene, S. [1 ]
机构：
[1] Yale Univ, Sch Med, Sect Hematol, Yale Canc Ctr, New Haven, CT USA
[2] Univ Klinikum Freiburg, Med Klin 1, Onkol & Stammzelltransplantat, Freiburg, Germany
[3] LMU Grosshadern, Med Klin 3, Hamatol & Onkol, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V540
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [41] SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis
    Lehmann, Ulrich
    Bartels, Stephan
    Hasemeier, Britta
    Geffers, Robert
    Schlue, Jerome
    Buesche, Guntram
    Hussein, Kais
    Kreipe, Hans
    BLOOD, 2013, 121 (19) : 4011 - 4012
  • [42] Functional Analysis of SRSF2 Mutations in Myelodysplastic Syndromes and Related Disorders
    Kon, Ayana
    Sanada, Masashi
    Yoshida, Kenichi
    Nagata, Yasunobu
    Shiraishi, Yuichi
    Sato, Yusuke
    Sato-Otsubo, Aiko
    Yamamoto, Ryo
    Nagasaki, Masao
    Suzuki, Yutaka
    Yamaguchi, Tomoyuki
    Otsu, Makoto
    Sugano, Sumio
    Chiba, Shigeru
    Koeffler, H. Phillip
    Shih, Lee-Yung
    Nakauchi, Hiromitsu
    Miyano, Satoru
    Ogawa, Seishi
    BLOOD, 2011, 118 (21) : 743 - 743
  • [43] SRSF2基因突变与髓系肿瘤
    苗宁宁
    孟凡凯
    曾雯
    秦爽
    罗丹
    孙汉英
    中国病理生理杂志, 2014, 30 (12) : 2289 - 2293
  • [44] SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?
    van Poppelen, Natasha M.
    Drabarek, Wojtek
    Smit, Kyra N.
    Vaarwater, Jolanda
    Brands, Tom
    Paridaens, Dion
    Kilic, Emine
    de Klein, Annelies
    CANCERS, 2019, 11 (08)
  • [45] MicroRNA and alternative splicing regulate the expression of SRSF2 in renal cancer
    Sokol, E.
    Boguslawska, J.
    Kedzierska, H.
    Poplawski, P.
    Rodzik, K.
    Rybicka, B.
    Tanski, Z.
    Piekielko-Witkowska, A.
    FEBS JOURNAL, 2015, 282 : 22 - 22
  • [46] Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms
    Wang, Borwyn A.
    Mehta, Hrishikesh M.
    Penumutchu, Srinivasa R.
    Tolbert, Blanton S.
    Cheng, Chonghui
    Kimmel, Marek
    Haferlach, Torsten
    Maciejewski, Jaroslaw P.
    Corey, Seth J.
    LEUKEMIA, 2022, 36 (10) : 2499 - 2508
  • [47] Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms
    Borwyn A. Wang
    Hrishikesh M. Mehta
    Srinivasa R. Penumutchu
    Blanton S. Tolbert
    Chonghui Cheng
    Marek Kimmel
    Torsten Haferlach
    Jaroslaw P. Maciejewski
    Seth J. Corey
    Leukemia, 2022, 36 : 2499 - 2508
  • [48] Clinicopathological Features of Isolated Thrombocytopenia Associated with SRSF2 Mutations: A Case Series
    Nwachukwu, Nneka
    O'Connell, Casey L.
    Vergara-Lluri, Maria
    Hagiya, Ashley
    O'Neill, Caitlin
    BLOOD, 2022, 140 : 11412 - 11413
  • [49] SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion
    Moon, Heegyum
    Cho, Sunghee
    Loh, Tiing Jen
    Jang, Ha Na
    Liu, Yongchao
    Choi, Namjeong
    Oh, Jagyeong
    Ha, Jiyeon
    Zhou, Jianhua
    Cho, Sungchan
    Kim, Dong-Eun
    Ye, Michael B.
    Zheng, Xuexiu
    Shen, Haihong
    BMB REPORTS, 2017, 50 (08) : 423 - 428
  • [50] BIOLOGICAL AND GENETIC CHARACTERIZATION OF THE ROLE OF SRSF2 MUTATIONS IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES
    Kon, Ayana
    Yamazaki, Satoshi
    Kataoka, Keisuke
    Yoshizato, Tetsuichi
    Shiozawa, Yusuke
    Sanada, Masashi
    Yoshida, Kenichi
    Nagata, Yasunobu
    Shiraishi, Yuichi
    Miyano, Satoru
    Haferlach, Torsten
    Nakayama, Manabu
    Koseki, Haruhiko
    Nakauchi, Hiromitsu
    Ogawa, Seishi
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S73 - S73
12345